REPOSITIONING DRUG OF GLP-1 AGONIST IN PARKINSON DISEASE BASED ON MACHINE LEARNING AND MOLECULAR DOCKING
This study aims to identify potential inhibitors of GLP-1 agonist drugs against ?Synuclein protein, relevant for Parkinson's treatment. Using data from CHEMBL (CHEMBL6152) and the crystal structure of the target ?-Synuclein (PDB ID 3Q28), a machine learning model was built with scikit-learn t...
Saved in:
Main Author: | Hasnia Putri, Haliza |
---|---|
Format: | Theses |
Language: | Indonesia |
Online Access: | https://digilib.itb.ac.id/gdl/view/81497 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Similar Items
-
Targeting GLP-1 receptor trafficking to improve agonist efficacy
by: Ben Jones, et al.
Published: (2019) -
Follow the Leader GLP-1 Agonist Liraglutide Demonstrates Cardioprotective Benefits
by: Sony Wibisono
Published: (2018) -
Choosing dopamine agonists in Parkinson's disease
by: Tan E.-K., et al.
Published: (2018) -
Dopamine agonists and their role in Parkinson's disease treatment
by: Tan E.-K.
Published: (2018) -
Peripheral edema and dopamine agonists in Parkinson disease [5]
by: Tan E.-K.
Published: (2018)